New targeted drug shows benefit against breast cancer in first phase III trial 08 Dec 2022 A new type of targeted medicine has shown ‘remarkable’ benefits for patients with advanced breast cancer in a major phase III clinical trial. Find out more Show/Hide
All patients’ cancers should be genetically profiled to improve care, say leading health experts 08 Aug 2022 The NHS should offer all cancer patients genetic profiling of their cancers at diagnosis and during treatment to shape care and track how the disease evolves, a consensus group of leading experts has concluded. Find out more Show/Hide
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide
AACR 2022: Team of scientists and clinicians wins global award for transforming breast cancer treatment 04 Apr 2022
AACR Annual Meeting 2021: Immunotherapy combination shows early promise in aggressive brain cancers 11 Apr 2021